A liquid biopsy (ctDNA, cfDNA) is the fastest way to determine what unique genetic mutations are driving your form of cancer. This simple blood test is quick, painless, and cost-effective. And just as significantly, it’s extremely informative: the data it provides helps us to choose the best targeted treatment for you.
In terms of precision oncology, liquid biopsy (ctDNA, cfDNA) is an essential tool that works in tandem with the other steps involved in creating an effective targeted treatment plan for your form of cancer. CTOAM’s precision oncology process is made up of six integral steps:
CTOAM’s six-step precision oncology process ensures that you will receive the best treatment available for your cancer, worldwide. This means that you’ll experience fewer and less severe side effects and superior survival rates compared to standard treatment. And throughout this process, CTOAM will act as your personal cancer care assistant: our care team will facilitate all of your tests, appointments, and treatments for you – so you can focus on getting better.
If you’d like to chat more about getting a liquid biopsy done, please email or call us today. Just imagine: if you got a liquid biopsy tomorrow, you could be starting on the correct targeted treatment within less than 10 days – compared to spending years with standard cancer care, getting the wrong treatment, and letting the cancer spread.
Your health and quality of life is worth investing in, don’t you think? There’s something better than standard treatment: precision oncology. Reach out to CTOAM and get the future of cancer treatment, now.
"I can’t tell you how much your support means to me. My call today with you was invaluable. You came into our lives at the perfect time. It’s rare to just be able to talk without a sales pitch. I could tell that my needs were more important." - Diane
Discover how you can get better cancer treatment! Get your questions answered now
Get the latest advancements in cancer care delivered straight to your inbox each month!
Discover the newest, leading-edge advancements in cancer care...